HUAWEI
At the sixth World Artificial Intelligence Conference (WAIC), UNIDO, Huawei, and other partners officially launched on 6 July 2023 the “Global Alliance on Artificial Intelligence for Industry and Manufacturing” (AIM Global). Led by UNIDO, AIM Global will integrate public and private partners to foster the use of and innovation around AI in industry and manufacturing.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230709545340/en/
Mr. Ciyong Zou, Deputy to the Director General and Managing Director of UNIDO, Vicky Zhang, Vice President of Corporate Communications at Huawei, and other partners during the official launch of AIM Global (Photo: Huawei)
Addressing the WAIC audience during the opening ceremony, Mr. Gerd Müller UNIDO Director General, said: “It is our shared responsibility to ensure that advancements in the field of AI are made in a manner that is safe, ethical, sustainable and inclusive. AIM Global recognizes the importance of bridging the digital divide between nations and industries, and ensuring that no one is left behind in the AI revolution. AIM Global will be at the forefront of shaping the AI landscape. Let us work collaboratively to build a future where AI is a force for good, where its benefits are accessible to all, and where innovation thrives in harmony with our shared values.”
“We are proud to be a strategic partner of AIM Global. Working closely with UNIDO and other Alliance partners, Huawei will use AI to bring new momentum to industry development,” said Vicky Zhang, Vice President Corporate Communications at Huawei. She added: “Huawei is building a strong foundation in computing capabilities and is launching multiple large models designed for specific industries. Our goal is to develop AI solutions that more effectively serve all industries – and that better support scientific research.”
The Alliance will benefit from the local networks and insights of UNIDO’s investment and technology promotion offices that offer support to SMEs globally. The resulting deep understanding of actual SME challenges across sectors will inform the strategy of AIM Global in order to maximize its impact. UNIDO is committed to supporting pioneering efforts to enhance industrial competitiveness and sustainable development through AI.
AIM Global will serve as a platform for collaboration, knowledge sharing, and the development of best practices. It will focus on four key areas. First, AIM Global will facilitate research and development of AI technologies specific to industry and manufacturing. Second, the Alliance and its partners will engage to develop and promote ethical guidelines for the use of AI in industry and manufacturing. Those will include environmental as well as societal criteria. Third, with the help of the Alliance UNIDO seeks to convey policy recommendations to governments and international organizations on the use of AI in industry and manufacturing. This shall drive the development of national AI strategies. Finally, AIM Global will promote the adoption of best practices for the use of AI in industry and manufacturing.
Huawei will actively support AIM Global with case studies on industrial AI implementation, insights from its intensive research and development as well as making its global network of experts available.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230709545340/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SBC Medical added to membership of Russell 3000® Index28.6.2025 01:30:00 CEST | Press release
SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical”), a global franchise and provider of services for aesthetic clinics, has been added as a member of the broad-market Russell 3000® Index, effective after the US market opens on June 30, as part of the 2025 Russell indexes reconstitution. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250608244276/en/ Yoshiyuki Aikawa-Director (Chairman), CEO Membership in the Russell 3000® Index, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000® Index or small-cap Russell 2000®Index as well as the appropriate growth and value style indexes. Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. According to the data as of the end of June 2024, about $10.6 trillion in assets are benchmarked against the Russell US indexes, which belong to
Altimetrik and SLK Software Join Forces to Create an AI-First Engineering Services Powerhouse27.6.2025 22:44:00 CEST | Press release
Altimetrik, a pure-play AI, Data and Digital engineering solutions company, today announced the signing of a definitive agreement to acquire SLK Software (“SLK”), a global technology services firm focused on delivering AI, intelligence automation and analytics solutions. The acquisition will further strengthen Altimetrik’s end-to-end enablement services and expand its customer reach, with a clear path to accelerate towards Altimetrik’s goal of reaching $1billion in annual revenue. The transaction remains subject to customary closing conditions and is expected to close in the second half of 2025. Financial details were not disclosed. Founded in 2000, SLK is recognized as a leader in the tech industry, and for its commitment to create innovative digital solutions. This strategic acquisition will significantly enhance the scale of Altimetrik’s capabilities, bringing together Altimetrik’s AI-first, platform-native engineering model and SLK’s full technology services stack that will further
Andersen Consulting udvider sine kompetencer inden for forretningstransformation med tilføjelsen af The Clearing27.6.2025 16:48:00 CEST | Pressemeddelelse
Andersen Consulting udbygger sin platform med samarbejdsfirmaet The Clearing, som er en managementkonsulentvirksomhed med speciale i organisatorisk omstilling og lederudvikling. The Clearing blev stiftet i 2009 og rådgiver kunder om komplekse udfordringer ved at afstemme ledelse, strategi, kultur og drift. Firmaet arbejder med føderale agenturer, virksomheder og nonprofitorganisationer med henblik på at skabe målbare forandringer på tværs af forskellige interessenter til gavn for en leders vision og strategi. Med dyb erfaring inden for flere sektorer, herunder national sikkerhed, sundhedspleje og finansielle tjenester, leder The Clearings unikke blanding af talent med ekspertise inden for organisationsudvikling, dataanalyse og visuel rådgivning forretningstransformationer i stor skala og arbejder sammen med kunder og eksperter for at sikre, at rådgivning omsættes til implementering. "Vi leverer transformative resultater, der ikke kun er i overensstemmelse med strategiske mål, men også
PRD Therapeutics Announces Initiation of First-in-Human Study for PRD00127.6.2025 16:00:00 CEST | Press release
PRD Therapeutics, Inc., a clinical stage company focused on the development of novel lipid metabolism regulators targeting homozygous familial hypercholesterolemia (HoFH) and metabolic dysfunction associated fatty liver disease (MASH/MASLD), today announced that the company recently initiated dosing in a First-in-Human (FIH) clinical trial of PRD001, a first-in-class SOAT2 (formerly known as ACAT2) selective inhibitor. “We are excited to initiate dosing in this clinical trial of PRD001. Many clinical trials have been conducted on SOAT1/2 dual or SOAT1 selective inhibitors, but this is the first clinical trial of an SOAT2 selective inhibitor” said Kanji Hosoda, Ph.D., CEO and co-founder of PRD Therapeutics. “Several results with SOAT1 or 2 knockout mice have been published, suggesting that knocking out or inhibiting only SOAT2 is crucial to demonstrate safety and efficacy. PRD001 is the world's first and only SOAT2-selective inhibitor and is expected to exhibit safety and efficacy in hu
STEMCELL Technologies Introduces STEMprep™ Tissue Dissociator System to Accelerate Research Discoveries27.6.2025 14:00:00 CEST | Press release
New instrument automates tissue processing for researchers in cancer, immunology and other science fields To help scientists accelerate their workflows, STEMCELL Technologies has commercially launched the STEMprep™ Tissue Dissociator System—a new benchtop instrument that automates, standardizes, and streamlines tissue dissociation, the process of breaking down tissue samples into single-cell suspensions for research purposes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250627342791/en/ To help scientists accelerate their workflows, STEMCELL Technologies has commercially launched the STEMprep™ Tissue Dissociator System—a new benchtop instrument that automates, standardizes, and streamlines tissue dissociation, the process of breaking down tissue samples into single-cell suspensions for research purposes. “Tissue dissociation is incredibly important for making advancements in research fields, like cancer and immunology, yet
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom